Triplebar Bio
Latest round
- Series A
Last raised
- Oct 2023
Total raised
- $20M
Investors
- 6
About Triplebar Bio
Founded in 2019 and based in California, US, Triplebar Bio, Inc. operates a biotechnology company that offers problem-solving in various fields, such as harnessing evolution at hyperspeed, microprocessors for biology, and hyper-throughput screening systems. The company was founded by Jeremy Agresti (CTO). The company has partnered with other companies to develop and scale up the production of cell-based proteins using precision fermentation. In October 2023, Triplebar Bio, Inc. The company's focus is on the healthcare and nutrition products industries. They employ a unique platform that combines hardware, software, biochemistry, and biology to examine millions of potential solutions daily, with the goal of expediting the discovery of innovative healthcare and nutrition products. The company actively tracks the impact of billions of mutations and routinely samples the genome. They operate at the intersection of biological and engineering sciences, aiming to engineer and discover microbes that can produce a wide variety of molecules for the food, agriculture, and pharmaceutical sectors.
Who invested in Triplebar Bio
6 investors across 1 round
See all investors in Triplebar Bio
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Oct 16, 2023
Amount
$20M
Investors
Questions about Triplebar Bio
Who invested in Triplebar Bio?
Triplebar Bio has 6 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Triplebar Bio raised?
Triplebar Bio has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Triplebar Bio last raise money?
Triplebar Bio's most recent round on record is a Series A, in Oct 2023.
What does Triplebar Bio do?
Founded in 2019 and based in California, US, Triplebar Bio, Inc.
Where is Triplebar Bio headquartered?
Triplebar Bio is headquartered in Emeryville, US.
Which VCs invest in companies like Triplebar Bio?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Triplebar Bio's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Triplebar Bio? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.